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Background:  Adult congenital heart disease (CHD) patients with pulmonary hypertension (PH) often have residual shunts. Interventions 
aim to optimize pulmonary flow and prevent right ventricular (RV) failure. However, eligibility for procedures depends on adaptation 
potential of pulmonary vasculature and right ventricle to circulatory changes. Guidelines are not sufficiently applicable to individual patients, 
who exhibit great diversity in cardiac disease.
methods:  We present four adult complex CHD-PH patients with ambiguous indication for shunt adjustment. The first patient with Fallots’ 
tetralogy developed RV dilatation after recanalization of a Potts’ shunt that was re-closed through percutaneous aortic stenting. The second 
and third patient had backgrounds of palliative surgery for pulmonary atresia and ventricular septum defect (VSD). One patient underwent 
fenestrated VSD closure and pulmonary stenting, the other underwent an atrioseptostomy to relieve RV overload. The last patient had a 
monoventricular circulation and severe mitral stenosis that resulted in pulmonary venous congestion and inotropic dependence, for which 
an atrioseptostomy was performed.
results:  Tailored intervention improved right heart hemodynamics and short term clinical functioning in all cases.
Conclusion:  Individual evaluation of disease characteristics is mandatory for tailored treatment. Strict registration of cases and multicenter 
cooperation are essential in the quest for optimal therapy.
 
